Themis Medicare Limited submitted a formal response to BSE Limited's Corporate Relationship Department regarding unusual trading volume movement in the company's securities.
The clarification was issued in response to BSE's email dated 23rd June 2026, which sought explanation for the increase in trading volume of the company's securities.
The company explicitly stated that there is no pending or delayed disclosure of any material information that should have been announced under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
The management affirmed that the company has been regularly disseminating all relevant information and details in compliance with SEBI listing regulations, maintaining timely disclosures as required.
The response was digitally signed by Sachin Dinesh Patel, Managing Director & CEO (DIN: 00033353), on 23rd June 2026 at 16:28:44 IST.
The document serves as an official compliance communication confirming that no material undisclosed information exists that could explain the unusual volume movement.